Director sold ~$33K of Penumbra, Inc.
Scheduled in advanceLoading…
PEN · NYSE · Health Care Equipment
Health Care Equipment company based in Alameda, California.
In the last 90 days, no insider of Penumbra, Inc. reported an open-market purchase and 0 open-market sales. Every figure links to its official SEC, House, Senate or USAspending record.
Last closeLast close, Oct 5, 2026
$317.11
Last 12 months
Not enough history
Market value
$12.5B
Revenue
$390M
+14.9% vs the same quarter a year earlier
Free cash flow, last 12 months
$216M
This quarter $32.5M, a year earlier $29.4M
Net debt
—
Debt —, cash $205M, at Jun 30, 2026
Net income, last 12 months
$161M
Operating profit covers interest 144.2x
From the company's own quarterly and annual reports to the SEC. Free cash flow (cash from operations minus capital spending), net debt (debt minus cash) and 12-month totals are calculated by OQRO. Production rates, deliveries, approvals and guidance are in its results announcement of Jul 30, 2026.
Insiders buying, last 90 days
None
No open-market purchases reported
Insiders selling, last 90 days
None
No open-market sales reported
New federal contracts, 12 months
None
Nothing found for this company
Revenue, fiscal 2025
$1.4B
+17.5% vs the year before
Net income, fiscal 2025
$178M
As reported in the annual filing
Shares outstanding
39.4M
As of Jul 14, 2026
Director sold ~$33K of Penumbra, Inc.
Scheduled in advanceCFO sold ~$832K of Penumbra, Inc.
Scheduled in advanceDirector sold ~$58K of Penumbra, Inc.
Scheduled in advanceDirector sold ~$1.52M of Penumbra, Inc.
Scheduled in advancePrices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
Last 12 months, adjusted daily closes
Adjusted close went from $255.61 on Oct 6, 2025 to $317.11 on Oct 5, 2026 (+24.1%). Disclosed activity in the last 12 months: 0 insider purchases, 32 insider sales (32 under pre-arranged plans), 0 Congress purchases, 0 Congress sales.